By later lines, CML stops being the “good cancer”

An image illustrating CML as a sinister bunny to emphasize by later lines, CML stops being the “good cancer” An image illustrating CML as a sinister bunny to emphasize by later lines, CML stops being the “good cancer”
By later lines, CML stops being the Good Cancer By later lines, CML stops being the Good Cancer

Later lines of CML may be associated with increased resistance and intolerance.1,6

An icon image of 2 tablets and 1 capsule, representing CML in later lines

There is an unmet need in later lines of CML.2,7,8

An icon image of the Earth connected to a microphone and stethoscope

Hear perspectives on CML and view our educational resources.

CML, chronic myeloid leukemia.

References: 1. Soverini S, Gnani A, Colarossi S, et al. Blood. 2009;114(10):2168-2171. 2. Garg RJ, Kantarjian H, O'Brien S, et al. Blood. 2009;114(20):4361-4368. 3. Ibrahim AR, Paliompeis C, Bua M, et al. Blood. 2010;116(25):5497-5500. 4. Gambacorti-Passerini C, Brummendorf TH, Kim D-W, et al. Am J Hematol. 2014;89(7):732-742. 5. Shah NP, Kim D-W, Kantarjian H, et al. Haematologica. 2010;95(2):232-240. 6. Kantarjian HM, Giles FJ, Bhalla KN, et al. Blood 2011;117(4):1141-1145. 7.  Bosi GR, Fogliatto LM, Costa TEV, et al. Hematol Transfus Cell Ther. 2019;41(3):222-228. 8. Iacob RE, Zhang J, Gray NS, Engen JR. PLoS One. 2011;6(1):e15929. 

This site is for US health care professionals only.

Use of website is governed by the Terms of Use and Privacy Policy

Copyright © 2021 Novartis Pharmaceuticals Corporation. All rights reserved.

 

9/21 152562